The tumor suppressor KCTD11 is down-regulated in NSCLC and KCTD11 overexpression inhibits lung cancer progression by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways [36]. This evidence concerns the gene KCTD11 and non-small cell lung carcinoma.